🔎 Trials Near Me

Home › Kidney Cancer (Renal Cell Carcinoma) › Pennsylvania › Harrisburg

Kidney Cancer (Renal Cell Carcinoma) clinical trials in Harrisburg, PA

4 studies for Kidney Cancer (Renal Cell Carcinoma) are looking for participants at sites in and around Harrisburg (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

RecruitingPhase 1
  • Exelixis Clinical Site #104, Hershey · 12 mi away
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT05176483

Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial

RecruitingPhase 2
  • UPMC Pinnacle Cancer Center/Community Osteopathic Campus, Harrisburg
  • UPMC Hillman Cancer Center at Rocco And Nancy Ortenzio Cancer Pavilion, Mechanicsburg · 8 mi away
  • Penn State Milton S Hershey Medical Center, Hershey · 12 mi away
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT05327686

A Randomized Trial of Fianlimab and Cemiplimab +/- Ipilimumab or Ipilimumab Plus Nivolumab in First-line Advanced Renal Cell Carcinoma (RCC)

RecruitingPhase 2
  • Penn State Cancer Institute, Hershey · 12 mi away
Ages 18 and older · All sexes · Updated Sep 4, 2026 · NCT07188896

Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer

RecruitingPhase 3
  • UPMC Pinnacle Cancer Center/Community Osteopathic Campus, Harrisburg
  • UPMC Hillman Cancer Center at Rocco And Nancy Ortenzio Cancer Pavilion, Mechanicsburg · 8 mi away
Ages 18 and older · All sexes · Updated Sep 2, 2026 · NCT06661720

Kidney Cancer (Renal Cell Carcinoma) trials in other cities

Other studies in Harrisburg

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.